Search
Compass Therapeutics Inc.
CMPXAdd to Watchlist
2.020USD
-0.030-1.46%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
363.78MMarket Cap
LossP/E TTM
Compass Therapeutics Inc.'s Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Compass Therapeutics Inc. is 8.70, ranking 96 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.06, which is -55.74% below the recent high of -2.24 and -206.36% above the recent low of -15.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
